Selbyville, Delaware, June 04, 2023 (GLOBE NEWSWIRE) --
Animal Antibiotics and Antimicrobials Market size will reach over USD 6.7 billion by 2032. Growing demand for animal protein products and the rising prevalence of infectious diseases in animals will fuel animal antibiotics and antimicrobials industry progress. As global populations continue to rise, the need for a sustainable and efficient source of protein is increasing. Animal protein products, such as meat, eggs, and dairy, are widely consumed globally, and increasing demand for these products has led to a surge in livestock farming.
Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/5608
Regulatory policies and government initiatives are also playing a significant role in driving animal antibiotics and antimicrobial market growth. As the importance of preventing and treating infectious diseases in animals becomes more widely recognized, governments around the world are implementing policies and initiatives to support the use of antibiotics and antimicrobial agents in livestock farming.
Increasing use of penicillin to treat zoonotic diseases
Animal antibiotics and antimicrobials market share from penicillin will grow notably over 2032. Penicillin is a widely administered antibiotic in animals owing to its ability to effectively treat a broad spectrum of bacterial infections. In livestock farming, penicillin is essential for preventing and treating bacterial infections that can severely impact the health and productivity of animals. By administering penicillin to livestock, farmers can maintain optimal growth, ensure food safety, and reduce the risk of zoonotic diseases. For companion animals such as dogs, cats, and horses, penicillin is crucial in treating various bacterial infections, which will further drive product demand.
Browse key industry insights spread across 200 pages with 341 market data tables & 17 figures & charts from the report, “Animal Antibiotics and Antimicrobials Market Size By Product Type (Tetracyclines, Penicillin, Sulfonamides, Macrolides, Aminoglycosides, Lincosamides, Fluoroquinolones, Cephalosporins), By mode of delivery (Premixes, Oral Solutions, Oral Powders, Injections), By animal type (Companion Animal {Dogs, Cats, Horses}, Livestock Animal {Cattle, Swine, Poultry, Sheep, Goats}) – Global Forecast to 2032” In detail along with the table of contents:
https://www.gminsights.com/industry-analysis/animal-antibiotics-and-antimicrobials-market
Rising prevalence of bacterial infections in companion animals
The Animal antibiotics and antimicrobials market is segmented into companion animals and livestock animals. Companion animals will hold a significant share of the animal antibiotics and antimicrobials industry by 2032. The rising pet ownership rate is boosting the need for effective treatments for bacterial infections. The rising number of households with companion animals has led to an increased demand for antibiotics, including penicillin. Pet owners are becoming more aware of the importance of maintaining their pets' health and are willing to invest in effective treatments to ensure their well-being. The growing prevalence of bacterial infections in companion animals has heightened the demand for antibiotics and antimicrobials.
Breakthroughs in innovative oral solutions for antibiotic treatments
The animal antibiotics and antimicrobials market is categorized into premixes, oral solutions, oral powders, and injections. Market share from oral solutions will increase over 2032. In recent years there has been a substantial surge in the development of innovative oral solutions for the administration of antibiotics. These solutions have made it easier for pet owners and farmers to provide effective treatment for animals suffering from bacterial infections.
Increasing meat consumption in APAC to drive industry growth
Asia Pacific animal antibiotics and antimicrobials market will exhibit robust growth over 2032 led by the growing demand for animal-derived food products, such as meat, dairy, and eggs. This growth has led to an increased need for antibiotics to maintain the health and productivity of livestock, driving the market's expansion. The increasing prevalence of zoonotic diseases has also heightened the demand for antibiotics and other treatments in animal healthcare creating a favorable environment for animal antibiotics and antimicrobial market growth across the Asia Pacific.
Secure a copy of the premium research report @ https://www.gminsights.com/securecheckout/paymenta/5608?gmpaycod=sugmp
Animal antibiotics and antimicrobials competitive landscape
Zoetis Inc., Elanco Animal Health Incorporated, Merck & Co., Inc., Boehringer Ingelheim International GmbH, Virbac, Ceva Sante Animal, Vetoquinol, Novartis AG, Bayer AG, Eli Lilly, Arthrex, and Sanofi are some of the leading companies in the market.
Partial Table of Contents (ToC) of the report:
Chapter 3 Animal Antibiotics and Antimicrobials Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Incresing demand for animal derived food products
3.2.1.2 Rising concerns regarding the health of animals
3.2.1.3 Growing incidences of diseases in animals
3.2.1.4 Rising adoption of companion animals
3.2.2 Industry pitfalls & challenges
3.2.2.1 Stringent approval process for antimicrobial and antibiotics
3.2.2.2 Increasing resistance to antibiotic
3.3 Growth potential analysis
3.3.1 By product type
3.3.2 By mode of delivery type
3.3.3 By animal type
3.4 COVID- 19 impact analysis
3.5 Regulatory landscape
3.6.1 U.S.
3.6.2 Europe
3.6 Industry ecosystem
3.7 Technology landscape
3.8 Porter's analysis
3.9 PESTEL analysis
Browse Our Reports Store - GMIPulse @ https://www.gminsights.com/gmipulse
About Global Market Insights
Global Market Insights Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider, offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy, and biotechnology.
